Your browser doesn't support javascript.
loading
Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.
Wu, Huali; Ramanathan, Ramesh K; Zamboni, Beth A; Strychor, Sandra; Ramalingam, Suresh; Edwards, Robert P; Friedland, David M; Stoller, Ronald G; Belani, Chandra P; Maruca, Lauren J; Bang, Yung-Jue; Zamboni, William C.
Afiliación
  • Wu H; University of North Carolina (UNC) Eshelman School of Pharmacy, UNC, Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North CarolinaUNC Institute for Pharmacogenomics and Individualized Therapy, UNC, Chapel Hill, North CarolinaCarolina Center for Cancer Nanotechology Excellence, UNC, Chapel Hill, North CarolinaUniversity of Pittsburgh Cancer Institute, Pittsburgh, PennsylvaniaSchool of Medicine, University of Pittsburgh, PittsburghDepartment of Mathematics
J Clin Pharmacol ; 52(2): 180-94, 2012 Feb.
Article en En | MEDLINE | ID: mdl-21233302
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Camptotecina / Inhibidores de Topoisomerasa I / Modelos Biológicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Pharmacol Año: 2012 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Camptotecina / Inhibidores de Topoisomerasa I / Modelos Biológicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Pharmacol Año: 2012 Tipo del documento: Article